Plant-derived natural compounds: A new frontier in inducing immunogenic cell death for cancer treatment - 23/07/24
Abstract |
Immunogenic cell death (ICD) can activate adaptive immune response in the host with normal immune system. Some synthetic chemotherapeutic drugs and natural compounds have shown promising results in cancer treatment by triggering the release of damage-associated molecules (DAMPs) to trigger ICD. However, most chemotherapeutic drugs exhibit non-selective cytotoxicity and may also induce and promote metastasis, thereby significantly reducing their clinical efficacy. Among the natural compounds that can induce ICD, plant-derived compounds account for the largest proportion, which are of increasing value in the treatment of cancer. Understanding which plant-derived natural compounds can induce ICD and how they induce ICD is crucial for developing strategies to improve chemotherapy outcomes. In this review, we focus on the recent findings regarding plant-derived natural compounds that induce ICD according to the classification of flavonoids, alkaloids, glycosides, terpenoids and discuss the potential mechanisms including endoplasmic reticulum (ER) stress, DNA damage, apoptosis, necroptosis autophagy, ferroptosis. In addition, plant-derived natural compounds that can enhance the ICD induction ability of conventional therapies for cancer treatment is also elaborated. The rational use of plant-derived natural compounds to induce ICD is helpful for the development of new cancer treatment methods.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Highlights |
• | Plant-derived natural compounds as ICD inducers are emerging for cancer therapies. |
• | Plant-derived compounds can enhance the ICD induction ability of conventional cancer therapies. |
• | Stress responses associated with ICD include ER stress, DNA damage. |
• | Apoptosis, necroptosis, autophagy, and ferroptosis are the main types of ICD-related deaths. |
• | Combining traditional methods of ICD induction with immunotherapy should be studied. |
Abbreviations : ICD, ER, DAMPs, CALR, HMGB1, ATP, HSP70/90, IFN, ANXA1, DCs, PD-1, eIF2α, DOX, ERp57, TLR4, CD4, PERK, GRP78, Bcl-2, Bax, PARP, CHOP, IRE1, NF-κB, MyD88, SNARE, PD-L1, LAMP1, p62, LC3, ERK, mTOR, p70S6K, TNF-α, Bak-1, BAD, MHC-II, APCs, ROS, MLKL, RIPK1, GPX4, P53, AIF, ATF-4, IL-2, TDP-43, cGAS, STING, NADPH, TGF-β1, XBP1s, GOT1, PDI, ERO1, MOMP, MMP, ULK1, Atg5, P2RY2, P2RX7, TRIF, RIP1, p38MAPK, JNK, SLC7A11, GSH, TFR-1, FSP1, TBK1, IRF3
Keywords : Immunogenic cell death, Natural compounds, Plants, Damage-associated molecular patterns, Cancer immunotherapy
Plan
Vol 177
Article 117099- août 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?